A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Staiger, Christine ^a,b   Cadot, Sidney ^b   Kooter, Raul ^c   Dittrich, Marcus ^d   Müller, Tobias ^d   Klau, Gunnar W ^a,e   Wessels, Lodewyk F A ^b,c  

^a CWI   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Faculty of Electrical Engineering Mathematics and Computer Science ^*  (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e Netherlands Institute for Systems Biology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER PROGNOSIS; CLASSIFICATION ALGORITHM; CLASSIFIER; CONTROLLED STUDY; DATA ANALYSIS; GENE IDENTIFICATION; INTERMETHOD COMPARISON; BIOLOGY; BREAST TUMOR; CLASSIFICATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; HUMAN; METHODOLOGY; PREDICTIVE VALUE; PROGNOSIS;

TUMOR MARKER;

BREAST NEOPLASMS; CLASSIFICATION; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860478431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034796     Document Type: Article

References (30)

1. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
2. Wang Y, Klijn JGM, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
3. Chuang HY, Lee E, Liu YT, Lee D, Ideker T, (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140.
4. Lee E, Chuang HY, Kim JW, Ideker T, Lee D, (2008) Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4: e1000217.
5. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. (2009) Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 27: 199-204.
6. Ma S, Shi M, Li Y, Yi D, Shia BC, (2010) Incorporating gene co-expression network in identi_cation of cancer prognosis markers. BMC Bioinformatics 11: 271.
7. Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J, (2010) Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics 11: 277.
8. Hanahan D, Weinberg R, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-74.
9. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
10. Popovici V, Chen W, Gallas BG, Hatzis C, Shi W, et al. (2010) Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Res 12: R5.
11. Wessels LFA, Reinders MJT, Hart AAM, Veenman CJ, Dai H, et al. (2005) A protocol for building and evaluating predictors of disease state based on microarray data. Bioinformatics (Oxford, England) 21: 3755-3762.
12. Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, et al. (2008) A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res 10: R93.
13. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AAM, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
14. Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, et al. (2010) A pathway-based classi_cation of human breast cancer. Proc Natl Acad Sci U S A 107: 6994-6999.
15. Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Müller T, (2008) Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics 24: i223-i231.
16. Ulitsky I, Krishnamurthy A, Karp RM, Shamir R, (2010) Degas: de novo discovery of dysregulated pathways in human diseases. PLoS One 5: e13367.
17. Chowdhury SA, Nibbe RK, Chance MR, Koyutürk M, (2011) Subnetwork state functions de_ne dysregulated subnetworks in cancer. J Comput Biol 18: 263-281.
18. Dao P, Colak R, Salari R, Moser F, Davicioni E, et al. (2010) Inferring cancer subnetwork markers using density-constrained biclustering. Bioinformatics (Oxford, England) 26: i625-31.
19. Ein-Dor L, Kela I, Getz G, Givol D, Domany E, (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21: 171-178.
20. van Vliet MH, Reyal F, Horlings HM, van de Vijver MJ, Reinders MJT, et al. (2008) Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability. BMC Genomics 9: 375.
21. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M, (2010) Kegg for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-D360.
22. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, et al. (2006) Human protein reference database-2006 update. Nucleic Acids Res 34: D411-D414.
23. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, et al. (2005) Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 102: 13544-13549.
24. Prasad TSK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human protein reference database-2009 update. Nucleic Acids Res 37: D767-D772.
25. Brown KR, Jurisica I, (2005) Online predicted human interaction database. Bioinformatics 21: 2076-2082.
26. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
27. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, et al. (2007) Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the transbig multicenter independent validation series. Clin Cancer Res 13: 3207-3214.
28. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, et al. (2007) Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 25: 1239-1246.
29. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
30. Pawitan Y, Bjhle J, Amler L, Borg AL, Egyhazi S, et al. (2005) Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 7: R953-R964.